That'd have to be an incredibly large one-time payment. And how would we know how much to pay?
It doesn't seem like an unsolvable problem. The drug companies themselves must have budgets, and the publicly traded ones have a stock price. So someone somewhere must be able to create estimates for this.
It doesn't seem like an unsolvable problem. The drug companies themselves must have budgets, and the publicly traded ones have a stock price. So someone somewhere must be able to create estimates for this.